Research and Postgraduate Pro-Rectory, Universidade do Sagrado Coração - USC, Rua Irmã Arminda 10-50, Jardim Brasil Bauru, SP, 17011-160, Brazil.
Oral Biology Doctoral's Program, Bauru School of Dentistry, São Paulo University - FOB/USP, Alameda Octávio Pinheiro Brizola 9-75, Vila Universitária, Bauru, SP, 17012-901, Brazil.
Clin Oral Investig. 2019 Jan;23(1):413-421. doi: 10.1007/s00784-018-2450-x. Epub 2018 Apr 26.
The aim of the study was to analyze bone matrix (BMX) organization after bone grafting and repair using a new bioactive glass-ceramic (Biosilicate) associated or not with particulate autogenous bone graft.
Thirty rabbits underwent surgical bilateral parietal defects and divided into groups according to the materials used: (C) control-blood clot, (BG) particulate autogenous bone, (BS) bioactive glass-ceramic, and BG + BS. After 7, 14, and 30 days post-surgery, a fragment of each specimen was fixed in - 80 °C liquid nitrogen for zymographic evaluation, while the remaining was fixed in 10% formalin for histological birefringence analysis.
The results of this study demonstrated that matrix organization in experimental groups was significantly improved compared to C considering collagenous organization. Zymographic analysis revealed pro-MMP-2, pro-MMP-9, and active (a)-MMP-2 in all groups, showing gradual decrease of total gelatinolytic activity during the periods. At day 7, BG presented more prominent gelatinolytic activity for pro-MMP-2 and 9 and a-MMP-2, when compared to the other groups. In addition, at day 7, a 53% activation ratio (active form/[active form + latent form]) was evident in C group, 33% in BS group, and 31% in BG group.
In general, BS allowed the production of a BMX similar to BG, with organized collagen deposition and MMP-2 and MMP-9 disponibility, permitting satisfactory bone remodeling at the late period.
The evaluation of new bone substitute, with favorable biological properties, opens the possibility for its use as a viable and efficient alternative to autologous bone graft.
本研究旨在分析使用新型生物活性玻璃陶瓷(Biosilicate)联合或不联合颗粒状自体骨移植进行骨移植和修复后的骨基质(BMX)组织。
30 只兔子接受双侧顶骨缺损手术,并根据使用的材料分为以下几组:(C)对照组-血凝块,(BG)颗粒状自体骨,(BS)生物活性玻璃陶瓷,和 BG+BS。术后 7、14 和 30 天,每个标本的一部分固定在-80°C 液氮中进行酶谱评估,其余部分固定在 10%甲醛中进行组织双折射分析。
与 C 组相比,实验组的基质组织在胶原组织方面得到了显著改善。酶谱分析显示所有组均存在前 MMP-2、前 MMP-9 和活性(a)-MMP-2,总明胶酶活性在各时期逐渐下降。在第 7 天,BG 组的前 MMP-2、9 和 a-MMP-2 的明胶酶活性较其他组更为明显。此外,在第 7 天,C 组的激活率(活性形式/[活性形式+潜伏形式])为 53%,BS 组为 33%,BG 组为 31%。
总的来说,BS 允许产生类似于 BG 的 BMX,具有组织化的胶原沉积和 MMP-2 和 MMP-9 的可用性,在晚期允许令人满意的骨重塑。
评估具有良好生物学特性的新型骨替代物为其作为自体骨移植的可行和有效替代物的应用提供了可能性。